Mathew Blackman
Stock Analyst at Stifel
(3.29)
# 1,041
Out of 5,031 analysts
61
Total ratings
54.76%
Success rate
14.43%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mathew Blackman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INGN Inogen | Maintains: Hold | $10 → $7 | $8.36 | -16.27% | 13 | May 8, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $60 → $31 | $14.79 | +109.60% | 6 | May 1, 2025 | |
| PEN Penumbra | Maintains: Buy | $301 → $318 | $249.00 | +27.71% | 2 | Apr 24, 2025 | |
| CLPT ClearPoint Neuro | Maintains: Buy | $19 → $25 | $25.38 | -1.48% | 3 | Apr 1, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $25 | $20.02 | +24.88% | 1 | Feb 24, 2025 | |
| PODD Insulet | Maintains: Hold | $245 → $293 | $318.59 | -8.03% | 5 | Feb 21, 2025 | |
| GMED Globus Medical | Maintains: Buy | $92 → $94 | $59.58 | +57.77% | 5 | Feb 21, 2025 | |
| OFIX Orthofix Medical | Upgrades: Buy | $18 → $24 | $15.07 | +59.26% | 5 | Nov 8, 2024 | |
| CERS Cerus | Maintains: Buy | $6 → $3 | $1.53 | +96.08% | 1 | Oct 17, 2024 | |
| DXCM DexCom | Maintains: Buy | $90 → $100 | $66.60 | +50.15% | 11 | Aug 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $16 | $14.89 | +7.45% | 5 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $18 → $11 | $9.14 | +20.35% | 4 | May 10, 2023 |
Inogen
May 8, 2025
Maintains: Hold
Price Target: $10 → $7
Current: $8.36
Upside: -16.27%
Tandem Diabetes Care
May 1, 2025
Maintains: Buy
Price Target: $60 → $31
Current: $14.79
Upside: +109.60%
Penumbra
Apr 24, 2025
Maintains: Buy
Price Target: $301 → $318
Current: $249.00
Upside: +27.71%
ClearPoint Neuro
Apr 1, 2025
Maintains: Buy
Price Target: $19 → $25
Current: $25.38
Upside: -1.48%
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $25
Current: $20.02
Upside: +24.88%
Insulet
Feb 21, 2025
Maintains: Hold
Price Target: $245 → $293
Current: $318.59
Upside: -8.03%
Globus Medical
Feb 21, 2025
Maintains: Buy
Price Target: $92 → $94
Current: $59.58
Upside: +57.77%
Orthofix Medical
Nov 8, 2024
Upgrades: Buy
Price Target: $18 → $24
Current: $15.07
Upside: +59.26%
Cerus
Oct 17, 2024
Maintains: Buy
Price Target: $6 → $3
Current: $1.53
Upside: +96.08%
DexCom
Aug 23, 2024
Maintains: Buy
Price Target: $90 → $100
Current: $66.60
Upside: +50.15%
Aug 1, 2024
Maintains: Buy
Price Target: $19 → $16
Current: $14.89
Upside: +7.45%
May 10, 2023
Downgrades: Hold
Price Target: $18 → $11
Current: $9.14
Upside: +20.35%